AUDENTES THERAPEUTICS INC - COM (BOLD)

CUSIP: 05070R104

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class
Equity / COM
Total 13F shares
43,113,813
Share change
+6,984,425
Total reported value
$919,169,824
Put/Call ratio
42%
Price per share
$21.32
Number of holders
125
Value change
+$134,248,878
Number of buys
81
Number of sells
38

Quarterly Holders Quick Answers

What is CUSIP 05070R104?
CUSIP 05070R104 identifies BOLD - AUDENTES THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of AUDENTES THERAPEUTICS INC - COM (BOLD) as of Q4 2018

As of 31 Dec 2018, AUDENTES THERAPEUTICS INC - COM (BOLD) was held by 125 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 43,113,813 shares. The largest 10 holders included WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, Partner Fund Management, L.P., BlackRock Inc., Redmile Group, LLC, ORBIMED ADVISORS LLC, Vanguard Group Inc, GREAT POINT PARTNERS LLC, STATE STREET CORP, and Versant Venture Management, LLC. This page lists 125 institutional shareholders reporting positions in this security for the Q4 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.